Washington University in St. Louis-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2021

  1. Phase 1b Study to Evaluate Safety, Tolerability, and Maximum Tolerated Dose of PF-05230907 for Intracerebral Hemorrhage

    Stroke, Vol. 52, Núm. 1, pp. 294-298